Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection.
about
Natural killer cells in hepatitis C: Current progressRegulation of hepatic innate immunity by hepatitis C virusImmune responses to HCV and other hepatitis virusesProtective immunity against hepatitis C: many shades of gray.Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patientsMechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?Drug resistance of a viral population and its individual intrahost variants during the first 48 hours of therapy.Natural Killer Cells in Viral Hepatitis.IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and diseaseHepatitis C Virus. Strategies to Evade Antiviral ResponsesReassessing immune control of hepatitis A virusRibavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN ProductionPathogenesis of chronic viral hepatitis: differential roles of T cells and NK cellsM2 Macrophages Play Critical Roles in Progression of Inflammatory Liver Disease in Hepatitis C Virus Transgenic Mice.Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation.Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.Role of macrophages and monocytes in hepatitis C virus infections.Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infectionThe impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.Organ system view of the hepatic innate immunity in HCV infection.Current progress in host innate and adaptive immunity against hepatitis C virus infection.Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatment.Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.Defining the spatial relationship between hepatitis C virus infection and interferon-stimulated gene induction in the human liver.Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease.Anti-inflammatory effects of propofol on lipopolysaccharides-treated rat hepatic Kupffer cells.New insight into the enhanced effect of pegylated interferon-α.Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice
P2860
Q26773264-63DC82D0-5FD7-45B2-BBB3-16E5893FC954Q26824743-A3FB44D7-8F51-4CAA-ABDB-F3372B837A65Q26866955-89E66E18-5F22-4B78-BA49-9A6314F1B158Q33759224-C238B59E-D23C-405F-8791-7E19804D3909Q33812840-31DBC843-4ED2-406B-9976-4ED8AE5FAA30Q33944295-31D175A3-68C1-4E58-88D3-1AB661D38EAEQ33946635-12ED8702-CF77-4EBE-8F70-DE3783EBE6D1Q34358742-1E916EC6-F2F3-41C7-9C0C-B27DDFEAF501Q34434371-D32E2F6D-08D3-4656-AD05-1A29F0A03EDCQ34505690-F8CE5971-E416-4537-9910-C77C86AA9F69Q34697945-DD6BFE56-5CD9-4D60-A44F-9BEE7EE65031Q35604054-0D0DB87C-B9AE-4108-AD52-DC34F2F28220Q35685377-1E066A5B-A598-4238-A280-661B9247B93EQ35746343-664F7627-2CCB-4B77-9C51-407DFDFEEAACQ35786326-465F5D51-6AA3-4A99-AD74-E3E909F372BBQ35807914-CEA71F90-16BE-425A-A75D-F87D5B52FBC7Q35893868-F7DA43C0-5AD4-4DA2-AB28-C4CBDB293354Q37679930-0CCE429C-65AE-4863-8421-F5BB92322C95Q37719756-32DAC410-FD81-465F-A5DE-79EF889FC422Q38198616-D0E00CAB-AB71-41AB-A29A-E4D83AC4EDB3Q38282854-9BADFBB8-E502-4CB3-AED0-D468D5C695B5Q38514365-FA3CBC1B-EBEB-45F0-AFC1-E9A47CD19C69Q38827613-9777204F-760A-4EB9-8885-97C0A36297BAQ39393253-758F3067-9D00-458A-A120-E6B2784B650CQ40484068-7C1B0249-9AD1-446C-AD82-D4D02F625738Q42218328-8AE5D684-C2BA-40E0-AD6F-1B1361B3E7A9Q42228703-3727876A-FCA3-464B-9DAB-1638B3F2EE43Q42232134-B9B17F1F-4A94-48D9-BD62-EE18B67BAD36Q45348391-B87AD4C1-AC65-4B8D-8F99-6D6D31134A35Q47556931-5A4CB1F0-816C-49FE-8FDB-0D19A61FF0A2Q47802725-973E262C-0244-4642-A891-C27A1B498481Q53940851-7415A5D7-5916-43DD-9255-287B56606A32Q56797663-87FDF2D3-4348-4090-AA54-6CAA4655F72D
P2860
Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@en
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@nl
type
label
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@en
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@nl
prefLabel
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@en
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@nl
P2093
P2860
P50
P1433
P1476
Innate immune tolerance and th ...... with HCV genotype 1 infection.
@en
P2093
Amina Negash
Bruce A Luxon
Daryl T-Y Lau
Mala Sinha
Nanette Crochet
Sharon Holder
Stanley M Lemon
Takeshi Saito
Yuhong Zhang
P2860
P304
402-413.e12
P356
10.1053/J.GASTRO.2012.10.044
P407
P577
2012-11-02T00:00:00Z